Concentrix Corporation (NASDAQ: CNXC), an outsourcing services provider headquartered in Newark, California, is scheduled to release its financial results for the fourth quarter on Tuesday, January 13, 2025, before market opening. Analysts surveyed anticipate that the company will report earnings per share (EPS) of approximately $2.91 for the period. This represents a contraction compared to the EPS of $3.26 reported for the same quarter a year earlier. Despite this expected earnings decline, quarterly revenue forecasts show an improvement, with a consensus estimate around $2.54 billion, surpassing the $2.45 billion recorded in the previous year’s fourth quarter, according to data aggregated by Benzinga Pro.
Concentrix’s recent financial disclosures have included some signs of pressure, with the company posting third-quarter results on September 25 that fell short of market expectations. Following that release, management offered subdued guidance for the fourth quarter, tempering outlooks for the upcoming earnings report.
The company’s shares responded to prior updates with a modest increase, closing at $43.88 on the Tuesday preceding the earnings announcement, reflecting a 2.9% gain. Investors and market watchers are keenly observing the upcoming report to gauge whether the revenue growth trend can offset declining profitability and how the company’s outlook might adjust further.
Leading analysts with strong track records of accurate forecasts have recently updated their ratings and price targets for Concentrix, reflecting varied sentiment within the investment community.
Barrington Research’s Vincent Colicchio, noted for an analyst accuracy rate of 58%, reiterated an Outperform rating on November 20, 2025, assigning a price target of $62 per share. This suggests confidence in the company’s medium-term prospects despite recent earnings challenges.
David Koning of Baird, who boasts a higher accuracy rate of 72%, maintained his Outperform rating but revised the price target down from $75 to $62 on September 29, 2025. This adjustment indicates a more cautious stance on valuation, possibly driven by the weaker-than-expected third-quarter performance and conservative outlook.
Similarly, Joseph Vafi of Canaccord Genuity, with an accuracy rate of 75%, sustained a Buy rating and assigned a more optimistic price target of $80 as of September 23, 2025, reflecting a more bullish viewpoint within the analyst community.
On the more cautious side, Ruplu Bhattacharya of B of A Securities, holding an accuracy rate of 68%, maintained a Neutral rating but lowered the price target from $65 to $61 on June 27, 2025, signaling tempered expectations for the stock’s near-term performance.
As the market awaits Concentrix’s official fourth-quarter earnings report, investors are encouraged to monitor analysts’ updated ratings and price targets. The company’s current stock price reflects some of the uncertainties surrounding the upcoming results.
Overall, the situation underscores a mixed consensus. While there is revenue growth, the earnings contraction and cautious guidance have led several analysts to reassess their valuations and expectations. Market participants should consider these factors carefully when evaluating Concentrix’s stock and the implications of the forthcoming earnings release.
For investors tracking Concentrix, continuously updated analyst opinions, price targets, and ratings are accessible on financial platforms that track equity analyst activity, facilitating more informed decision-making ahead of earnings disclosures.
Concentrix’s recent financial disclosures have included some signs of pressure, with the company posting third-quarter results on September 25 that fell short of market expectations. Following that release, management offered subdued guidance for the fourth quarter, tempering outlooks for the upcoming earnings report.
The company’s shares responded to prior updates with a modest increase, closing at $43.88 on the Tuesday preceding the earnings announcement, reflecting a 2.9% gain. Investors and market watchers are keenly observing the upcoming report to gauge whether the revenue growth trend can offset declining profitability and how the company’s outlook might adjust further.
Leading analysts with strong track records of accurate forecasts have recently updated their ratings and price targets for Concentrix, reflecting varied sentiment within the investment community.
Barrington Research’s Vincent Colicchio, noted for an analyst accuracy rate of 58%, reiterated an Outperform rating on November 20, 2025, assigning a price target of $62 per share. This suggests confidence in the company’s medium-term prospects despite recent earnings challenges.
David Koning of Baird, who boasts a higher accuracy rate of 72%, maintained his Outperform rating but revised the price target down from $75 to $62 on September 29, 2025. This adjustment indicates a more cautious stance on valuation, possibly driven by the weaker-than-expected third-quarter performance and conservative outlook.
Similarly, Joseph Vafi of Canaccord Genuity, with an accuracy rate of 75%, sustained a Buy rating and assigned a more optimistic price target of $80 as of September 23, 2025, reflecting a more bullish viewpoint within the analyst community.
On the more cautious side, Ruplu Bhattacharya of B of A Securities, holding an accuracy rate of 68%, maintained a Neutral rating but lowered the price target from $65 to $61 on June 27, 2025, signaling tempered expectations for the stock’s near-term performance.
As the market awaits Concentrix’s official fourth-quarter earnings report, investors are encouraged to monitor analysts’ updated ratings and price targets. The company’s current stock price reflects some of the uncertainties surrounding the upcoming results.
Overall, the situation underscores a mixed consensus. While there is revenue growth, the earnings contraction and cautious guidance have led several analysts to reassess their valuations and expectations. Market participants should consider these factors carefully when evaluating Concentrix’s stock and the implications of the forthcoming earnings release.
For investors tracking Concentrix, continuously updated analyst opinions, price targets, and ratings are accessible on financial platforms that track equity analyst activity, facilitating more informed decision-making ahead of earnings disclosures.